Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa.

Abstract:

:Because free factor VIIa is inactivated only very slowly by a plasma concentration of antithrombin III (AT III) even in the presence of heparin, it has been assumed that AT III plays no significant role in regulating the initiation of tissue factor-dependent blood coagulation. However, in the present study, we present evidence that factor VIIa bound to tissue factor, unlike free factor VIIa, is readily inactivated by AT III in the presence of heparin. In a reaction mixture containing calcium ions and approximately equimolar concentrations of relipidated tissue factor (8.9 nmol/L) and factor VIIa (10 nmol/L), AT III (100 micrograms/mL) plus heparin (1 U/mL) inhibited 50% of the factor VIIa coagulant activity of the reaction mixture within 5 minutes. AT III/heparin was also shown to inhibit the catalytic activity towards factor X of factor VIIa/tissue factor complexes formed on monolayers of an ovarian carcinoma cell line (OC-2008) that constitutively expresses surface membrane tissue factor. AT III, even in the absence of exogenously added heparin, substantially inhibited the functional activity of factor VIIa/cell surface tissue factor complexes on intact monolayers. AT III alone and AT III/heparin, to a greater extent, also inhibited factor VIIa on "nonfunctional" factor VIIa/tissue factor complexes on intact monolayers, with resultant inhibition of their expression of factor VIIa/tissue factor catalytic activity toward factor X after cell lysis. The potential physiologic significance of these findings is discussed.

journal_name

Blood

journal_title

Blood

authors

Rao LV,Rapaport SI,Hoang AD

subject

Has Abstract

pub_date

1993-05-15 00:00:00

pages

2600-7

issue

10

eissn

0006-4971

issn

1528-0020

journal_volume

81

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.

    abstract::Several lines of evidence indicate that macrophage inflammatory protein-1alpha (MIP-1alpha) modulates the proliferation of hematopoietic progenitor cells, depending on their maturational stages. To clarify the mechanisms for the modulation of hematopoiesis by this chemokine, we examined the expression of a receptor fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Su S,Mukaida N,Wang J,Zhang Y,Takami A,Nakao S,Matsushima K

    更新日期:1997-07-15 00:00:00

  • RANK ligand and osteoprotegerin in myeloma bone disease.

    abstract::Myeloma bone disease is due to interactions of myeloma cells with the bone marrow microenvironment, and is associated with pathologic fractures, neurologic symptoms and hypercalcemia. Adjacent to myeloma cells, the formation and activation of osteoclasts is increased, which results in enhanced bone resorption. The rec...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2002-09-2684

    authors: Sezer O,Heider U,Zavrski I,Kühne CA,Hofbauer LC

    更新日期:2003-03-15 00:00:00

  • Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.

    abstract::We have investigated the role of plasminogen activator inhibitor 1 (PAI-1) in the regulation of fibrinolysis using a model thrombus composed of thrombin-stimulated platelets, fibrin(ogen), plasminogen, and recombinant tissue-type plasminogen activator. Laser light scattering kinetic measurements showed that clot lysis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Braaten JV,Handt S,Jerome WG,Kirkpatrick J,Lewis JC,Hantgan RR

    更新日期:1993-03-01 00:00:00

  • The effect of isoferritins on granulopoiesis.

    abstract::The evidence for a regulatory role of acidic isoferritins on hemopoiesis is not entirely consistent with our knowledge of ferritin biochemistry, and no clear picture of this phenomeonon has emerged. In the present study, we have been unable to confirm a consistent effect of purified heart (acidic), spleen (basic), or ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sala G,Worwood M,Jacobs A

    更新日期:1986-02-01 00:00:00

  • Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase.

    abstract::Angiogenesis, the formation of new capillaries from preexisting blood vessels, is a multistep, highly orchestrated process involving vessel sprouting, endothelial cell migration, proliferation, tube differentiation, and survival. Eicosanoids, arachidonic acid (AA)-derived metabolites, have potent biologic activities o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nie D,Tang K,Diglio C,Honn KV

    更新日期:2000-04-01 00:00:00

  • Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation.

    abstract::The Wiskott-Aldrich syndrome (WAS) is a severe immunodeficiency and platelet deficiency disease arising from mutation(s) in the WASP gene, which in normal cells encodes an intracellular protein able to interact with other proteins relevant to the control of cytoskeleton organization. Immunodeficiency is mainly due to ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gallego MD,Santamaría M,Peña J,Molina IJ

    更新日期:1997-10-15 00:00:00

  • Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.

    abstract::Ferroportin (FPN) mediates iron export from cells; FPN mutations are associated with the iron overloading disorder hemochromatosis. Previously, we found that the A77D, V162del, and G490D mutations inhibited FPN activity, but that other disease-associated FPN variants retained full iron export capability. The peptide h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0561

    authors: Drakesmith H,Schimanski LM,Ormerod E,Merryweather-Clarke AT,Viprakasit V,Edwards JP,Sweetland E,Bastin JM,Cowley D,Chinthammitr Y,Robson KJ,Townsend AR

    更新日期:2005-08-01 00:00:00

  • Transfusion-associated AIDS: donor-recipient human immunodeficiency virus exhibits genetic heterogeneity.

    abstract::The genetic diversity of the human immunodeficiency virus (HIV) isolated from transfusion-associated AIDS patients has been examined. Restriction enzyme mapping studies of integrated proviral DNA of donor and recipient origin demonstrated genomic variation between isolates. Analysis of the molecularly cloned viral gen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Srinivasan A,York D,Ranganathan P,Ferguson R,Butler D Jr,Feorino P,Kalyanaraman V,Jaffe H,Curran J,Anand R

    更新日期:1987-06-01 00:00:00

  • Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor.

    abstract::Conditioned medium (CM) obtained from a human hepatoma cell line, SK-HEP-1, contains colony-stimulating factors (CSFs) active on murine and human bone marrow-derived granulocyte and macrophage colony-forming units (CFU-GM) and a factor capable of inducing granulocyte-macrophage differentiation (GM-DF) of murine myelom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gabrilove JL,Welte K,Lu L,Castro-Malaspina H,Moore MA

    更新日期:1985-08-01 00:00:00

  • Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia.

    abstract::People with hemophilia were formerly at very high risk of infection with hepatitis C virus (HCV). Approximately 20% of HCV-infected patients spontaneously clear the virus. To identify correlates of spontaneous clearance of HCV, we studied a cohort of HCV-infected hemophilic subjects without human immunodeficiency viru...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2005-07-2781

    authors: Zhang M,Rosenberg PS,Brown DL,Preiss L,Konkle BA,Eyster ME,Goedert JJ,Second Multicenter Hemophilia Cohort Study.

    更新日期:2006-02-01 00:00:00

  • Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations.

    abstract::The anemia of chronic disease (ACD) results from 3 major processes: slightly shortened red cell survival, impaired reticuloendothelial system iron mobilization, and impaired erythropoiesis. Hepcidin is an acute-phase protein with specific iron regulatory properties, which, along with the anemia seen with increased hep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2854

    authors: Dallalio G,Law E,Means RT Jr

    更新日期:2006-04-01 00:00:00

  • Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies.

    abstract::Interleukin-3 (IL-3) has been shown to be a promising agent in the stimulation of bone marrow regeneration following myeloablative therapy. The biologic half-life of this agent is very short (5 to 15 minutes), which limits the effectiveness of low-dose therapy. Here we show that the biologic effects of low-dose IL-3 i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones AT,Ziltener HJ

    更新日期:1993-08-15 00:00:00

  • Slug deficiency enhances self-renewal of hematopoietic stem cells during hematopoietic regeneration.

    abstract::Both extrinsic and intrinsic mechanisms tightly govern hematopoietic stem cell (HSC) decisions of self-renewal and differentiation. However, transcription factors that can selectively regulate HSC self-renewal division after stress remain to be identified. Slug is an evolutionarily conserved zinc-finger transcription ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-232934

    authors: Sun Y,Shao L,Bai H,Wang ZZ,Wu WS

    更新日期:2010-03-04 00:00:00

  • BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.

    abstract::Mutations in the Bcr-Abl kinase domain may cause, or contribute to, resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia patients. Recommendations aimed to rationalize the use of BCR-ABL mutation testing in chronic myeloid leukemia have been compiled by a panel of experts appointed by the Europe...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-12-326405

    authors: Soverini S,Hochhaus A,Nicolini FE,Gruber F,Lange T,Saglio G,Pane F,Müller MC,Ernst T,Rosti G,Porkka K,Baccarani M,Cross NC,Martinelli G

    更新日期:2011-08-04 00:00:00

  • Paxillin selectively associates with constitutive and chemoattractant-induced high-affinity alpha4beta1 integrins: implications for integrin signaling.

    abstract::Leukocyte alpha4beta1 integrins regulate hematopoietic and lymphoid development, as well as the emigration of circulating cells to sites of inflammation. Because vascular cell adhesion molecule-1 (VCAM-1) binding to high-affinity alpha4beta1 is stable, these integrins can be detected and selectively precipitated from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4402

    authors: Hyduk SJ,Oh J,Xiao H,Chen M,Cybulsky MI

    更新日期:2004-11-01 00:00:00

  • Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.

    abstract::Advances in immune assessment, including the development of T-cell receptor excision circle (TREC) assays of thymopoiesis, cytokine-flow cytometry assays of T-cell function, and higher-order phenotyping of T-cell maturation subsets have improved our understanding of T-cell homeostasis. Limited data exist using these m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-05-092130

    authors: Komanduri KV,St John LS,de Lima M,McMannis J,Rosinski S,McNiece I,Bryan SG,Kaur I,Martin S,Wieder ED,Worth L,Cooper LJ,Petropoulos D,Molldrem JJ,Champlin RE,Shpall EJ

    更新日期:2007-12-15 00:00:00

  • Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes.

    abstract::Alloreactive T cells present in a bone marrow transplant are responsible for graft-versus-host disease (GVHD), but their depletion is associated with impaired engraftment, immunosuppression, and loss of the graft-versus-leukemia effect. We developed a therapeutic strategy against GVHD based on the selective destructio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cohen JL,Boyer O,Salomon B,Onclercq R,Charlotte F,Bruel S,Boisserie G,Klatzmann D

    更新日期:1997-06-15 00:00:00

  • Targeting neovascularization in GVHD.

    abstract::In this issue of Blood, Leonhardt et al report that neovascularization during graft-versus-host disease (GVHD) is regulated by av integrins and the micro RNA miR-100. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-01-480483

    authors: Komanduri KV

    更新日期:2013-04-25 00:00:00

  • VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

    abstract::Hairy cell leukemia variant (HCLv) presents with high disease burden, lack of typical antigens like CD25, and poor response to standard treatments like cladribine. Occasionally, patients with classic HCL respond poorly. Clinical and molecular features of HCL and HCLv has not been compared. Rearrangements expressing im...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-201731

    authors: Arons E,Suntum T,Stetler-Stevenson M,Kreitman RJ

    更新日期:2009-11-19 00:00:00

  • Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.

    abstract::Sixty-five patients with hairy cell leukemia underwent splenectomy; 27 had a complete remission as defined by a return in WBC, RBC, and platelet counts to a defined level, and 38 had a partial remission with a return of only one or two of these parameters to the defined level. The 5-yr actuarial survival for all patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Golomb HM,Vardiman JW

    更新日期:1983-02-01 00:00:00

  • Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.

    abstract::The cellular immune defect in untreated Hodgkin's disease (HD) has long been recognized. This defect appears to be responsible for at least some of the morbidity and ultimately the mortality associated with the disease. In recent years, many studies have shown that the T cell component of the immune response is the ap...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ford RJ,Tsao J,Kouttab NM,Sahasrabuddhe CG,Mehta SR

    更新日期:1984-08-01 00:00:00

  • Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cells.

    abstract::Caveolin-1 (Cav-1) is a key organizer of membrane specializations and a scaffold protein that regulates signaling in multiple cell types. We found increased Cav-1 expression in human and murine T cells after allogeneic hematopoietic cell transplantation. Indeed, Cav-1(-/-)donor T cells caused less severe acute graft-v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672428

    authors: Schönle A,Hartl FA,Mentzel J,Nöltner T,Rauch KS,Prestipino A,Wohlfeil SA,Apostolova P,Hechinger AK,Melchinger W,Fehrenbach K,Guadamillas MC,Follo M,Prinz G,Ruess AK,Pfeifer D,del Pozo MA,Schmitt-Graeff A,Duyster J,H

    更新日期:2016-04-14 00:00:00

  • Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

    abstract::Lymphatic endothelial cells (LECs) induce peripheral tolerance by direct presentation to CD8 T cells (T(CD8)). We demonstrate that LECs mediate deletion only via programmed cell death-1 (PD-1) ligand 1, despite expressing ligands for the CD160, B- and T-lymphocyte attenuator, and lymphocyte activation gene-3 inhibitor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-427013

    authors: Tewalt EF,Cohen JN,Rouhani SJ,Guidi CJ,Qiao H,Fahl SP,Conaway MR,Bender TP,Tung KS,Vella AT,Adler AJ,Chen L,Engelhard VH

    更新日期:2012-12-06 00:00:00

  • ADAMTS13 turns 3.

    abstract::It has now been 3 years since the von Willebrand factor (VWF)-cleaving protease implicated in thrombocytopenic purpura (TTP) pathogenesis was identified as ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13). More than 50 ADAMTS13 mutations resulting in familial TTP have been reported...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2004-10-4097

    authors: Levy GG,Motto DG,Ginsburg D

    更新日期:2005-07-01 00:00:00

  • Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses.

    abstract::Fifty patients with Philadelphia chromosome-positive (Ph(+)) chronic myelogenous leukemia (CML) in early chronic phase received imatinib mesylate, 400 mg orally daily. After a median follow-up of 9 months, 49 patients (98%) achieved a complete hematologic response and 45 patients (90%) achieved a major cytogenetic res...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-02-0545

    authors: Kantarjian HM,Cortes JE,O'Brien S,Giles F,Garcia-Manero G,Faderl S,Thomas D,Jeha S,Rios MB,Letvak L,Bochinski K,Arlinghaus R,Talpaz M

    更新日期:2003-01-01 00:00:00

  • Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

    abstract::A global phase 3 study evaluated the pharmacokinetics, efficacy, and safety of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in 63 previously treated male patients (12-61 years) with severe hemophilia B (factor IX [FIX] activity ≤2%). The study included 2 groups: group 1 patients recei...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2015-09-669234

    authors: Santagostino E,Martinowitz U,Lissitchkov T,Pan-Petesch B,Hanabusa H,Oldenburg J,Boggio L,Negrier C,Pabinger I,von Depka Prondzinski M,Altisent C,Castaman G,Yamamoto K,Álvarez-Roman MT,Voigt C,Blackman N,Jacobs I,PROLONG

    更新日期:2016-04-07 00:00:00

  • Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin.

    abstract::Intravenous immunoglobulin (IVIgG) causes an acute rise in the platelet count in the majority of patients with chronic immune thrombocytopenic purpura (ITP) but the mechanism(s) of action is still unknown. We evaluated the ability of three different IVIgG preparations to inhibit the in vitro binding of autoantibody to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Berchtold P,Dale GL,Tani P,McMillan R

    更新日期:1989-11-15 00:00:00

  • Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis.

    abstract::Depressed cellular immune function and increased susceptibility to infection characterize familial erythrophagocytic lymphohistiocytosis (FEL), a usually fatal autosomal recessive disease. One component of the immunodeficiency is plasma-mediated inhibition of lymphocyte proliferation. We have tested whether repeated p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ladisch S,Ho W,Matheson D,Pilkington R,Hartman G

    更新日期:1982-10-01 00:00:00

  • Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients.

    abstract::Platelet von Willebrand factor (vWF) has been suggested to play an important role in the hemostatic process. Clinical and experimental data indicate that bleeding time (BT) and platelet-vessel wall interaction cannot be normalized unless the defect of platelet vWF is also corrected. We have examined the effect of norm...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Castillo R,Monteagudo J,Escolar G,Ordinas A,Magallón M,Martín Villar J

    更新日期:1991-05-01 00:00:00

  • Formation and functioning of the factor IXa-VIII complex on the surface of endothelial cells.

    abstract::The formation and functioning of the factor X activating complex on the surface of cultured human venous endothelial cells (HVEC) were investigated. To the HVEC monolayer human factors IXa, VIII, X, CaCl2, and S-2222 were added, and a gradually increasing activation of factor X was observed. The maximum activity of 88...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Váradi K,Elödi S

    更新日期:1987-02-01 00:00:00